Medicure Sales And Marketing Effort Underway Following Aggrastat Acquisition

Merck separately acquires the right of first refusal for a combination of Aggrastat and Medicure’s investigational cardio-protective compound, the firm says.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet